Loading
JPXHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
¥306
¥0.00 · 0.00%
Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in the production and distribution of both prescription and over-the-counter pharmaceuticals across the country. Their diverse offerings include Strong Wakamoto, a widely recognized gastrointestinal aid formulated to enhance digestion, regulate intestinal health, and supplement nutrition. Additionally, the company provides AVANTBISE oral tablets, a dietary supplement designed to rebalance the oral microbiome, as well as various medicated toothpastes. Founded in 1929, the enterprise was initially known as Society for Nutrition and Raising Children Co., Ltd. before formally changing its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943.
Latest quote
¥306
¥0.00 · 0.00%
Regular session · JST · Market data may be delayed.
Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in the production and distribution of both prescription and over-the-counter pharmaceuticals across the country. Their diverse offerings include Strong Wakamoto, a widely recognized gastrointestinal aid formulated to enhance digestion, regulate intestinal health, and supplement nutrition. Additionally, the company provides AVANTBISE oral tablets, a dietary supplement designed to rebalance the oral microbiome, as well as various medicated toothpastes. Founded in 1929, the enterprise was initially known as Society for Nutrition and Raising Children Co., Ltd. before formally changing its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943.
Day range
Current ¥306
52-week range
Current ¥306
Regular session · JST · Market data may be delayed.
Headquartered in Tokyo, Japan, Wakamoto Pharmaceutical Co., Ltd. specializes in the production and distribution of both prescription and over-the-counter pharmaceuticals across the country. Their diverse offerings include Strong Wakamoto, a widely recognized gastrointestinal aid formulated to enhance digestion, regulate intestinal health, and supplement nutrition. Additionally, the company provides AVANTBISE oral tablets, a dietary supplement designed to rebalance the oral microbiome, as well as various medicated toothpastes. Founded in 1929, the enterprise was initially known as Society for Nutrition and Raising Children Co., Ltd. before formally changing its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943.
Day range
Current ¥306
52-week range
Current ¥306
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (JPY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.91B JPY | 7.79B JPY | 7.74B JPY | 8.66B JPY | 8.38B JPY |
| Cost of goods sold | 5.18B JPY | 4.17B JPY | 4.2B JPY | 4.55B JPY | 4.03B JPY |
| Gross profit | 4.73B JPY | 3.62B JPY | 3.54B JPY | 4.11B JPY | 4.36B JPY |
| Research and development | — | 419.08M JPY | 513.31M JPY | 580.45M JPY | 593.96M JPY |
| Selling, general, and administrative | 4.47B JPY | 4.08B JPY | 3.22B JPY | 3.33B JPY | 3.78B JPY |
| Operating expenses | 4.47B JPY | 4.08B JPY | 3.74B JPY | 3.97B JPY | 4.37B JPY |
| Interest income | 2.59M JPY | 1.43M JPY | 29K JPY | 28K JPY | 25K JPY |
| Interest expense | 1.9M JPY | 882K JPY | 531K JPY | 578K JPY | 575K JPY |
| Depreciation and amortization | 442.93M JPY | 430.34M JPY | 345.46M JPY | 363.65M JPY | 470.08M JPY |
| Operating income | 255.54M JPY | −457.8M JPY | −195.51M JPY | 141.47M JPY | −13.39M JPY |
| Net income | 227.22M JPY | 64.44M JPY | 108.96M JPY | 138.26M JPY | 238.54M JPY |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
¥3.00
2025 complete year0.0% since 2017
2026 partial: ¥3.50
¥3.00
2,017
¥3.00
2,018
¥3.00
2,023
¥3.00
2,024
¥3.00
2,025
¥3.50
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
DividendUpcoming | Mar 30, 2027 | ¥3.50Annual | Mar 31, 2027 | Mar 30, 2027 |
Dividend | Mar 30, 2026 | ¥3.50Annual | Mar 31, 2026 | Jun 23, 2026 |
Dividend | Mar 28, 2025 | ¥3.00Annual | Mar 31, 2025 | Jun 25, 2025 |
Dividend | Mar 28, 2024 | ¥3.00Annual | Mar 31, 2024 | Jun 28, 2024 |
Dividend | Mar 30, 2023 | ¥3.00Annual | Mar 31, 2023 | Jun 28, 2023 |
Dividend | Mar 28, 2018 | ¥3.00Annual | Mar 31, 2018 | Jun 22, 2018 |
Ex-dividend Mar 30, 2027
¥3.50
Annual
Record Mar 31, 2027 · Payment Mar 30, 2027
Ex-dividend Mar 30, 2026
¥3.50
Annual
Record Mar 31, 2026 · Payment Jun 23, 2026
Ex-dividend Mar 28, 2025
¥3.00
Annual
Record Mar 31, 2025 · Payment Jun 25, 2025
Ex-dividend Mar 28, 2024
¥3.00
Annual
Record Mar 31, 2024 · Payment Jun 28, 2024
Ex-dividend Mar 30, 2023
¥3.00
Annual
Record Mar 31, 2023 · Payment Jun 28, 2023
Ex-dividend Mar 28, 2018
¥3.00
Annual
Record Mar 31, 2018 · Payment Jun 22, 2018
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
